Neptune Responds to Enzymotec's Continuous Attempts to Shift Focus From ITC Investigation

By: via Benzinga
Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq: NEPT), announced today that the United States Patent ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.